HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Giovanni Battista Luciani Winfield J. Wells Vaughn A. Starnes Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Luciani, G. B. Articles by Starnes, V. A. Search for Related Content PubMed PubMed Citation Articles by Luciani, G. B. Articles by Starnes, V. A.

Ann Thorac Surg 1997;64:1133-1139
© 1997 The Society of Thoracic Surgeons

---

Original Article: Cardiovascular

Continuous Versus Intermittent Furosemide Infusion in Critically Ill Infants After Open Heart Operations

Divisions of Cardiothoracic Surgery and Pediatric Intensive Care, Childrens Hospital Los Angeles, Los Angeles, California

Background. Use of intravenous furosemide is generally avoided in critically ill neonates and infants soon after open heart operations to prevent fluctuations in intravascular volume and resulting circulatory instability.

Methods. To assess and compare the safety and efficacy of continuous versus intermittent intravenous furosemide, we undertook a prospective, randomized trial in 26 consecutive patients less than 6 months of age. Inclusion criteria were presence of low-output syndrome requiring inotropic support (24/26 patients) or pulmonary hypertension requiring vasodilator therapy (10/26 patients) within 6 hours of discontinuation of cardiopulmonary bypass. Eleven patients received 0.1 mg • kg^-1 • h^-1 continuous intravenous furosemide (group 1) and 15 received 1 mg/kg bolus every 4 hours (group 2) for 24 hours. Mean age (3.7 ± 3.4 versus 1.8 ± 2.5 months) and weight (4.6 ± 2.1 versus 4.3 ± 1.7 kg) were comparable.

Results. Group 2 infants showed slightly greater absolute urinary output (2.5 ± 1.1 mL/kg per hour versus 3.3 ± 1.1 mL/kg per hour, p = 0.05). However, urinary output per dose of drug was significantly larger in group 1 infants (1.0 ± 0.4 versus 0.5 ± 0.2 mL • kg^-1 • h^-1; p = 0.002) with lesser fluctuations (variance, 1.9 ± 1.6 versus 3.8 ± 2.1; p = 0.02) and fluid replacement needs (20.6 ± 3.8 versus 51.8 ± 14.4; p = 0.001). Electrolyte replacement requirements were similar. A trend toward greater hemodynamic instability in group 2 patients (heart rate variance 88.4 ± 79.8 versus 128.3 ± 82.7; p = 0.09; central venous pressure variance 2.8 ± 1.90 versus 4.1 ± 3.7; p = 0.07; mixed venous oxygen saturation variance, 32.3 ± 27.6 versus 45.7 ± 20.4; p = 0.06) was noted. All patients who completed the study protocol survived operation and were discharged home.

Conclusions. We conclude that (1) commonly used doses of both intermittent and continuous intravenous furosemide infusion can be safely administered to critically ill neonates and infants as early as 6 hours after operation, (2) continuous infusion yields an almost comparable urinary output with a much lower dose of furosemide, and (3) intermittent administration is associated with greater fluctuations in urinary output and greater needs for fluid replacement therapy.

This article has been cited by other articles:

				N E Moghal and M Shenoy Furosemide and acute kidney injury in neonates Arch. Dis. Child. Fetal Neonatal Ed., July 1, 2008; 93(4): F313 - F316. [Abstract] [Full Text] [PDF]

				B. E Gulbis and A. P Spencer Efficacy and Safety of a Furosemide Continuous Infusion Following Cardiac Surgery Ann. Pharmacother., October 1, 2006; 40(10): 1797 - 1803. [Abstract] [Full Text] [PDF]